Feedback / Questions
nintedanib inhaled (AP02) - Avalyn Pharma
https://www.globenewswire.com/news-release/2023/11/09/2777290/0/en/Avalyn-Presents-Data-from-its-AP01-and-AP02-Inhaled-Therapeutics-Programs-for-Pulmonary-Fibrosis.html
Nov 9, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next